205393-22-2 Bortezomib-pinanediol
| 상품명칭 |
Bortezomib-pinanediol |
| 영문 이름 |
Bortezomib-pinanediol; Bortezomib pinanediol ester; n-[(1s)-2-[[(1r)-1-[(3as,4s,6s,7ar)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]amino]-2-oxo-1-(phenylmethyl)ethyl]-2-pyrazinecarboxamide; n-[(1s)-1-benzyl-2-({(1r)-3-methyl-1-[(1s,2s,6r,8s)-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0~2,6~]dec-4-yl]butyl}amino)-2-oxoethyl]-2-pyrazinecarboxamide; bortezomib intermediates iii; Bortezomib Intermediate III |
| 분자식 |
C29H39BN4O4 |
| 분자량 |
518.46 |
| cas번호 |
205393-22-2 |
| 분자 구조 |
|
| 밀도 |
1.19 |
| 위험성 표시 |
|
| 리스크 규칙 |
|
| 보안 규칙 |
|
|
KR
CN
EN
DE
JP
RU
CZ
ES
FR
GR
HU
ID
IN
IL
IR
IT
MY
NL
NO
PL
PT
SA
TR
